MedImmune.com uses bio technology to develop medicine & health care
Title
MedImmune
Description
MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. The company has four marketed products and an advancing pipeline of promising candidates, all designed to treat or prevent a number of debilitating or life-threatening diseases.
With more than 2,200 employees worldwide, MedImmune is headquartered in Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom and the Netherlands. The company relocated its corporate headquarters to a new state-of-the-art facility in March 2004, designed to place research functions at the core and enhance the collaborative potential of researchers and developers.
Languages
English
Additional Information
Related Domains
External Links
- Stock: MEDI
- Alexa: MedImmune.com
- Amifostine
- Biopharmaceuticals
- Biotechnology
- Biotechnology And Pharmaceuticals
- Business
- Cmv
- Cyto Gam
- Cytomegalovirus
- Ethyol
- Gaithersburg
- Globulin
- Human
- Immune
- Intravenous
- Maryland
- Neu Trexin
- Palivizumab
- Pharmaceuticals
- Rsv
- Respi Gam
- Respiratory
- Respiratory Syncytial Virus
- Synagis
- Syncytial
- United States
- Vaccines
- Virus
- Biotechnology and Pharmaceuticals
- Business and Economy
- CMV
- CytoGam
- Cytomegalovirus Immune Globulin Intravenous
- Localities
- NeuTrexin
- North America
- RSV
- Regional
- RespiGam
- Trimetrexate Glucuronate For Injection